Narayana Hrudayalaya Ltd. · NSE:NH
Narayana Hrudayalaya — Q3 FY25 Earnings Presentation
20 slides from Narayana Hrudayalaya's earnings presentation, Feb 14, 2025
Slide 1: Exchange submission letter for Investor Presentation
Date of submission: February 14, 2025 To, To, The Secretary The Secretary Listing Department Listing Department BSE Limited National Stock Exchange of India Department of Corporate Services Limited Phiroze Jeejeebhoy Towers, Exchange Plaza, Bandra Kurla Complex Dalal Street, Mumbai – 400 001 Mumbai
Slide 2: Earnings Update Q3 FY25
Earnings Update Q3 FY25 August 02, 2023
Slide 3: Index
Topic Slide No. Our Footprint 03 Narayana Health at a Glance 04 Q3 FY25 Highlights 05 Index Capex 13 NH Integrated Care and Insurance 14 Digital Transformation Initiatives 15 Narayana Health ESG Vision – “Health For All” 16 Shareholding Pattern 17 2
Slide 4: Our Footprint
Our Footprint South As on 1st January 2025 Hospitals - 6 | Heart Centres - 2 | Clinics - 12 | Diagnostic Centre - 1 Kakriyal, Jammu Operational beds - 2,021 (Hospitals) - 128 (Heart Centres) Delhi NCR East Hospitals - 7 | Clinics - 4| Dialysis Centre - 1 Jaipur Operational beds - 2,039 Guwahati Ahme
Slide 5: Narayana Health – At Glance
Narayana Health – At Glance 6,313 Facility Details No. of Facilities Operational Beds Capacity Beds Owned / Operated Hospitals(1) 19 5,611 5.7 Mns(2) Average Effective Capital Cost per Operational Bed Heart Centres 2 128 Clinics and Dialysis Centre 19 0 Total 19,687 Clinical : 11,938 Non-clinical :
Slide 6: Key Highlights – Operational & Financial Performance (Q3 FY25)
Key Highlights – Operational & Financial Performance (Q3 FY25) • Narayana Institute of Cardiac Sciences (NICS), Bengaluru has successfully performed the following procedures : • 93 Robotic Cardiac Surgeries • 34 Transcatheter Aortic Valve Implantation (TAVI) • Mazumdar Shaw Medical Centre (MSMC), Be
Slide 7: India Operations – Revenue (Q3 FY25)
INR Mns India Operations – Revenue (Q3 FY25) Total* Domestic 15,004 12,004 10,816 10,365 11,677 10,869 8,729 10,004 9,585 10,004 -6.9% QoQ 8,004 -4.2% QoQ 6,004 5,004 4,004 2,004 4 4 Q3 FY24 Q2 FY25 Q3 FY25 Q3 FY24 Q2 FY25 Q3 FY25 13.4% YoY 18.7% YoY International Integrated Care - NHIC and NHIL 900
Slide 8: India Operations – Revenue Mix (Q3 FY25)
India Operations – Revenue Mix (Q3 FY25) Business Mix(6) Specialty-Profile(4,7) Payor-Profile(4,7) 4% 17% 28% 31% 21% 4% 45% 8% 1% 69% 9% 1% 13% 30% 17% Owned Hospitals (1) Cardiac Sciences Medicine and GI sciences Domestic Walk-in patients Operated Hospitals (2) Oncology Renal Sciences Insured Pati
Slide 9: Operational Review – India (Q3 FY25)
Operational Review – India (Q3 FY25) Average Revenue Per Patient (IP & OP) (1,2) ALOS INR ‘000 133.5 Days 123.0 129.6 4.5 4.4 4.4 4.3 4.3 OP 4.1 IP 3.9 4.2 4.3 4.4 3.7 Q3 FY24 Q2 FY25 Q3 FY25 Q3 FY24 Q2 FY25 Q3 FY25 Patient Footfalls (IP & OP)(1,3) 110 ICU Occupied Bed Days 705 ‘000 ‘000 104 604 620
Slide 10: Cluster Split – India (Q3 FY25)
Cluster Split – India (Q3 FY25) This considers owned/operated hospitals & heart centers in India (excl. Jammu (1)) Southern Eastern Western Bangalore Kolkata Northern Peripheral Peripheral • NICS • Mysore • RTIICS • Jamshedpur • Mumbai • Gurugram Regions • MSMC • Shimoga • Barasat • Guwahati • Ahmed
Slide 11: Profitability Snapshot – India Hospitals (Q3 FY25)
Profitability Snapshot – India Hospitals (Q3 FY25) Excludes NHIC, NHIL, ATHMA & MEDHA (2) EBITDA and EBITDA Margin (1) Cost Structure INR ‘Mns % of Operating Revenues Chart Title Share Rental / Revenue (7) 21.0% 21.0% 2,400 3% 2% 2% 20.0% 100% 2,200 90% 12% 12% 12% 19.1% 2,000 80% (6) 19.0% 18% (5)
Slide 12: Operational Review – Cayman Islands
Operational Review – Cayman Islands Average Revenue Per Patient (IP & OP) Operating Revenues US$ ‘00040.0 34.9 US$ Mns 31.9 36.0 35.1 30.7 30.0 34.0 OP 32.0 30.6 IP 20.0 29.0 30.0 10.0 28.0 1.2 1.4 1.3 26.0 0.0 24.0 Q3 FY24 Q2 FY25 Q3 FY25 Q3 FY24 Q2 FY25 Q3 FY25 Discharges Out-Patients 650 630 10,5
Slide 13: Consolidated Financial Performance
Consolidated Financial Performance Figures in INR Mns, unless stated otherwise Profit and Loss Statement(1) Key Balance Sheet Items(1) Particulars (INR Mns) Q3 FY25 9M FY25 Particulars 31st Dec 2024 Total Operating Revenue 13,667 41,076 Shareholder Equity 34,368 Consumption 2,763 8,648 Doctors Expen
Slide 14: Expansion: Progress Status & Capex Strategy
Expansion: Progress Status & Capex Strategy Building to strengthen our presence in flagship regions Current Bed Capacity Bed Capacity Addition Bed Capacity Target 00 0 0 00 CAPEX (INR Mn) FY25 (P) FY25 (A) 0 0 Greenfield/Inorganic 9100 1842 Brownfield/ Capacity Addition 1350 243 Replacement/Maintena
Slide 15: NH Integrated Care and Insurance: Snapshot
NH Integrated Care and Insurance: Snapshot Program running since September 2022 at select Bengaluru locations 10 106,261 ₹104.2 Mn ₹6.5 Mn Q3 FY25 Q3 FY25 YTD Q3 FY25 As on 31st December 2024 Points of Presence Patient Transactions Revenue - Integrated Care GWP - Insurance Integrated Care now availa
Slide 16: Digital Transformation Initiatives
Digital Transformation Initiatives Impact | Mobile Apps Launch | New Products Initiatives | Business GTM | Athma • 75% in patient documents • Digitized service workflow from digitized with mobile app • Mobile-based reporting app for booking to reporting • India: 100 beds added • All nursing assessme
Slide 17: NH ESG Vision – “Health For All”
Actual FY 24~25 9M (T – Target FY 24~25 9M) NH ESG Vision – “Health For All” A Healthy Planet By being conscious about impact on the environment, prioritizing consumption efficiency and resource optimization 35% Carbon Neutral 100% Optimized 50% less Renewable Energy By 2040 Waste-water Waste manage
Slide 18: Shareholding Pattern
Shareholding Pattern As on 31st Dec 2024(1) ESOP Trust DIIs 0.7% Total Number of Shares 10.2% 204,360,804 FIIs 9.4% Key DIIs Key FIIs Nippon Life India Asset Management Vanguard Index Funds Axis Asset Management Franklin Templeton Investment Funds DSP Asset Management Simcah Partners LP Others Promo
Slide 19: Disclaimer and Contact Details
Disclaimer and Contact Details No representation or warranty, express or implied is made as to, and no reliance should be placed on, the fairness, accuracy, completeness or correctness of such information or opinions contained herein. The information contained in this presentation is only current as
Slide 20: Take Care
i. C Take Care